23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
The year 2020 was an eventful one in the world of healthcare antitrust. The year began with the anno...
Read More >
We surveyed 550 participants, including GCs, heads of legal or equivalent, chief information securit...
Read More >
On October 24, 2019, Judge Cathy Seibel of the Southern District of New York issued her ruling grant...
Read More >
On June 25, 2019, Governor Jay B. Pritzker signed the Cannabis Regulation and Tax Act (HR1438) (“Ca...
Read More >
On September 18, California Governor Gavin Newsom signed AB 5 into law, and the new law will become ...
Read More >
On April 1, 2020, ODOT provided direction on enforcement of COVID-19 social distancing on ODOT proje...
Read More >